Literature DB >> 420107

Hemodynamic effects of dobutamine in children.

D J Driscoll, P C Gillette, D F Duff, M R Nihill, H P Gutgesell, T A Vargo, C E Mullins, D G McNamara.   

Abstract

Dobutamine is useful for augmenting cardiovasuclar function in adults. However, no information is available on the action of dobutamine in children. To determine its hemodynamic effects in children, we infused dobutamine into 12 children with congenital heart disease during diagnostic cardiac catheterization. We administered dobutamine in two doses: first 2 and then 7.75 microgram/kg per min for 10 minutes each. We meaured heart rate, cardiac output, systemic and pulmonary arterial, right atrial and pulmonary capillary blood pressures before and during the infusion of dobutamine. Systemic and pulmonary vascular resistances, cardiac index and stroke index were calculated. Cardiac output, cardiac index, stroke volume, stroke index and systemic arterial phasic and mean blood pressures increased sugnificantly (P less than 0.05) and pulmonary capillary mean blood pressure decreased significantly (P less than 0.05) during the infusion of each dose of dobutamine compared with control values. Heart rate, pulmonary and right atrial mean blood pressure and systemic and pulmonary vascular resistance were unchanged with either dose of dobutamine. We noted no adverse effect from the drug.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420107     DOI: 10.1016/0002-9149(79)90016-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Contributions of the Texas Children's Hospital Pediatric Cardiology Program to the field of pediatric cardiology.

Authors:  J T Bricker
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  Clinical Pharmacology Studies in Critically Ill Children.

Authors:  Nilay Thakkar; Sara Salerno; Christoph P Hornik; Daniel Gonzalez
Journal:  Pharm Res       Date:  2016-09-01       Impact factor: 4.200

3.  Randomized trial comparing dopamine and dobutamine in preterm infants.

Authors:  A Greenough; E F Emery
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

4.  Hemodynamic effects of dobutamine in children with cardiovascular failure.

Authors:  D Schranz; H Stopfkuchen; B K Jüngst; R Clemens; P Emmrich
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

5.  Pharmaceutical management of decompensated heart failure syndrome in children: current state of the art and a new approach.

Authors:  Avihu Z Gazit; Phineas P Oren
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-10

6.  Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals.

Authors:  H Stopfkuchen; D Schranz; R Huth; B K Jüngst
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

Review 7.  A Literature Review of the Pharmacokinetics and Pharmacodynamics of Dobutamine in Neonates.

Authors:  Liam Mahoney; Geetika Shah; David Crook; Hector Rojas-Anaya; Heike Rabe
Journal:  Pediatr Cardiol       Date:  2015-09-07       Impact factor: 1.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.